Kyle Gano

Companies

• Neurocrine BiosciencesBoard member Nov 1, 2024 to now¹
• Neurocrine BiosciencesChief executive officer Nov 1, 2024 to now¹
• Neurocrine BiosciencesChief Business Dev Officer Jan 28, 2013 to Feb 15, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX154,728 shares³$21.2M at $136.95Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 994 shares at $156.22 of Neurocrine Biosciences³
• Sep 11, 2026Granted 1,842 shares of Neurocrine Biosciences³
• Sep 11, 2026Shares withheld for tax 3,386 shares at $156.22 of Neurocrine Biosciences³
• Sep 11, 2026Granted 6,275 shares of Neurocrine Biosciences³
• Feb 13, 2026Shares withheld for tax 5,378 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Granted 9,968 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 1,385 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 2,566 shares of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 1,210 shares at $124.12 of Neurocrine Biosciences⁴
• Feb 13, 2026Exercised options 2,241 shares of Neurocrine Biosciences⁴
• Feb 12, 2026Shares withheld for tax 2,648 shares at $123.10 of Neurocrine Biosciences⁴
• Feb 12, 2026Exercised options 4,907 shares of Neurocrine Biosciences⁴
• Jan 31, 2026Shares withheld for tax 1,580 shares at $136.06 of Neurocrine Biosciences⁵
• Jan 31, 2026Exercised options 2,927 shares of Neurocrine Biosciences⁵
• Jan 16, 2026Sold 1,812 shares at $132.71 of Neurocrine Biosciences⁶
• Jan 16, 2026Exercised options 1,812 shares at $35.99 of Neurocrine Biosciences⁶
• Jan 16, 2026Sold 34,588 shares at $132.70 of Neurocrine Biosciences⁶
• Jan 16, 2026Exercised options 34,588 shares at $35.99 of Neurocrine Biosciences⁶
• Nov 4, 2025Sold 300 shares at $141.97 of Neurocrine Biosciences⁷
• Nov 1, 2025Exercised options 613 shares of Neurocrine Biosciences⁷
• Feb 13, 2025Sold 1,206 shares at $116.86 of Neurocrine Biosciences⁸
• Feb 13, 2025Exercised options 2,241 shares of Neurocrine Biosciences⁸
• Feb 13, 2025Sold 1,352 shares at $116.84 of Neurocrine Biosciences⁸
• Feb 13, 2025Exercised options 2,566 shares of Neurocrine Biosciences⁸
• Feb 10, 2025Sold 980 shares at $118.39 of Neurocrine Biosciences⁹